awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36436763-0876F77C-8494-44E9-A33E-B6F061BA840A
Q36436763-0876F77C-8494-44E9-A33E-B6F061BA840A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36436763-0876F77C-8494-44E9-A33E-B6F061BA840A
Integrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR2 as Targets for Growth Inhibition of Prostate Cancer.
P2860
Q36436763-0876F77C-8494-44E9-A33E-B6F061BA840A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36436763-0876F77C-8494-44E9-A33E-B6F061BA840A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4c5b04f195af228428725274fc6ec5e44e0908b7
P2860
Platinum-based chemotherapy for variant castrate-resistant prostate cancer.